Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12607000562471Phase 3Completed
Phase 3, randomised, double-blind trial in delirium comparing Oral risperidone, Oral haloperidol and Placebo syrup (3 arms). Primary endpoint: Target symptom score on Nursing Delirium Screening Scale. Started Aug 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12607000562471.